Please use this identifier to cite or link to this item:
Title: Current perspectives in percutaneous atrial septal defect closure devices.
Authors: Bissessor, Naylin
Keywords: Department of Cardiology, Epworth HealthCare, Melbourne
Atrial Septal Defect
Percutaneous Atrial Septal Defect Closure
Percutaneous Atrial Septal Defect Closure Devices
Gore Helex
Medical Devices
Heart Surgery
Congenital Heart Defect
Cardiothoracic Surgery
Cardiac Surgical Procedures
Issue Date: Jul-2015
Publisher: Dove Medical Press
Citation: Med Devices (Auckl). 2015 Jul 15;8:297-303
Abstract: In the last decade, percutaneous atrial septal defect (ASD) closure has become the treatment of choice in most clinical presentations of ASD. Percutaneous ASD closure has established procedural safety through operator experience and improved device structure and deliverability. There have also been advances in diagnostic capabilities. Devices have evolved from large bulky meshes to repositionable, minimal residual mesh content that easily endothelializes and conforms well to surrounding structures. Biodegradable technology has been introduced and will be closely watched as a future option. The evolution of ASD closure device usage in the last four decades incorporates development that minimizes a wide range of serious side effects that have been reported over the years. Complications reported in the literature include thrombus formation, air embolization, device embolization, erosions, residual shunts, and nickel hypersensitivity. Modern devices have intermediate to long term data with outcomes that have been favorable. Devices are available in multiple sizes with improved delivery mechanisms to recapture, reposition, and safely close simple and complex ASDs amenable to percutaneous closure. In this review, commonly used devices and deployment procedures are discussed together with a look at devices that show promise for the future.
DOI: 10.2147/MDER.S49368
PubMed URL:
ISSN: 1179-1470
Journal Title: Medical devices (Auckland, N.Z.)
Type: Journal Article
Affiliated Organisations: Division of Interventional Cardiology, The Alfred Hospital, Melbourne, VIC, Australia
Heart Foundation, Griffith University, QLD, Australia
Department of Clinical Science, Charles Sturt University Albury Campus, NSW, Australia
Type of Clinical Study or Trial: Review
Appears in Collections:Cardiac Sciences

Files in This Item:
File Description SizeFormat 
11434.404.pdfFull text2.66 MBAdobe PDFView/Open

Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.